← Back to Search
Zinc Supplement Before or With Food in Generally Healthy Men
Oakland, CA
N/A
Waitlist Available
Led By Jung Suh, PhD
Research Sponsored by UCSF Benioff Children's Hospital Oakland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0, day 15
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to determine the influence of food consumption timing on the body's response to a zinc supplement
Eligible Conditions
- Dyslipidemia
- Inflammation
- Zinc Deficiency
- Zinc Toxicity
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 0, day 15
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0, day 15
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Plasma Zinc changes
Secondary study objectives
Blood glucose changes
Body weight changes
Essential Fatty acid changes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: supplement prior to foodExperimental Treatment1 Intervention
Zinc supplement to be taken 30-min before breakfast consumption
Group II: Supplement with foodExperimental Treatment1 Intervention
Zinc supplement to be taken at time of breakfast consumption
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Zinc supplement
2009
Completed Phase 4
~270
Find a Location
Closest Location:UCSF Benioff Children's Hospital Oakland Research Institute· Oakland, CA
Who is running the clinical trial?
UCSF Benioff Children's Hospital OaklandLead Sponsor
79 Previous Clinical Trials
19,016 Total Patients Enrolled
8 Trials studying Dyslipidemia
971 Patients Enrolled for Dyslipidemia
Jung Suh, PhDPrincipal InvestigatorUCSF Benioff Children's Hospital Oakland Research Institute
1 Previous Clinical Trials
40 Total Patients Enrolled